Current position:Home >Product >
		
		
	
N-(4-chlorophenyl)-7-(2-methylphenoxy)-4-(4-methylphenyl)-3H-1,5-benzodiazepin-2-amine
N-(4-chlorophenyl)-7-(2-methylphenoxy)-4-(4-methylphenyl)-3H-1,5-benzodiazepin-2-amine
| 
 |  | 
Canonical SMILES:
CC1=CC=C(C=C1)C2=NC3=C(C=CC(=C3)OC4=CC=CC=C4C)N=C(C2)NC5=CC=C(C=C5)Cl
Isomeric SMILES
CC1=CC=C(C=C1)C2=NC3=C(C=CC(=C3)OC4=CC=CC=C4C)N=C(C2)NC5=CC=C(C=C5)Cl
InChI
InChI=1S/C29H24ClN3O/c1-19-7-9-21(10-8-19)26-18-29(31-23-13-11-22(30)12-14-23)33-25-16-15-24(17-27(25)32-26)34-28-6-4-3-5-20(28)2/h3-17H,18H2,1-2H3,(H,31,33)
 
      
		
	   Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- ethyl 2-(4-methoxyphenyl)-7-[(2-methoxyphenyl)methyl]-3-methyl-4-oxidanylidene-thieno[2,3-b]pyridine-5-carboxylate
- ethyl 4-(3,4-dimethoxyphenyl)-2-[(1-methylimidazol-2-yl)sulfanylmethyl]quinoline-3-carboxylate
- ethyl 4,6-bis(chloranyl)-3-[(E)-3-[(2-fluoranyl-3-nitro-phenyl)amino]-3-oxidanylidene-prop-1-enyl]-1H-indole-2-carboxylate
- tert-butyl (E)-6-[6-methoxy-4-(2-methoxyethoxymethoxy)-7-methyl-3-oxidanylidene-1,2-dihydroisoindol-5-yl]-4-methyl-hex-4-enoate
- [(2R,3S,4R,5R,6R)-2-(methoxymethyl)-5-oxidanyl-3-phosphonooxy-6-(2-propylpentoxy)oxan-4-yl] dihydrogen phosphate
- 2-[(E)-4,8-dimethyl-7,8-bis(oxidanyl)non-3-enyl]-8-(2-hydroxyethyl)-2-methyl-3,5-bis(oxidanyl)-4,9-dihydro-3H-pyrano[2,3-e]isoindol-7-one
- [(4aR,6R,7R,8S,8aS)-6-methoxy-2-phenyl-7-phosphonooxy-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-8-yl] benzoate
- methyl 2-(2-oxidanylidene-3-phenyl-3-phenylseleninyl-1,4-dihydroquinolin-4-yl)ethanoate
- 6-methoxy-2-methyl-5-phenylmethoxy-4-(4-phenylmethoxyphenyl)-1H-isoquinoline
- disodium (3E)-3-[(4-methylphenyl)hydrazinylidene]-4-oxidanylidene-naphthalene-2,7-disulfonate

 
               
       
